EP: 1.Emerging BTKi Combinations in CLL: A New Frontier of Treatment Options EP: 2.Clinical Implications and Unmet Needs in CLL BTKi Therapies EP: 3.Navigating New BTKi Treatment Strategies in Mantle Cell Lymphoma EP: 4.Integrating Emerging BTKi Therapies Into Current Treatment Guidelines EP: ...
Medscape Medical NewsMay 16, 2025 Too many physicians quietly battle anxiety and panic disorders. These doctors say treatment and openness saved their careers and changed their lives. ‘Legal Morphine’ — The Rise of Kratom and 7-OH in the US ...
Fast Five Quiz: Chronic Lymphocytic Leukemia (CLL) Treatment Fast Five Quiz April 24, 2025 Unprecedented Case of Rhabdomyoma in a Young Boy Clinical Case April 24, 2025 Fast Five Quiz: Early-Stage Breast Cancer Fast Five Quiz April 24, 2025 Reports View All Where Doctors Are Comfortab...
Fast Five Quiz: Chronic Lymphocytic Leukemia (CLL) Treatment Fast Five Quiz April 24, 2025 1 Unprecedented Case of Rhabdomyoma in a Young Boy Clinical Case April 24, 2025 Fast Five Quiz: Early-Stage Breast Cancer Fast Five Quiz April 24, 2025 4 Reports View All Where Doctors Are ...
The article reports that the National Institute for Clinical Excellence (NICE) in Great Britain has issued a final guidance on the treatment of cancer. NICE recommended the use of bendamustine for patients suffering from chronic lymphocytic leukaemia (CLL). The agency also suggested that advanced ...
News and CommentOutcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL Adam S. Kittai Ying Huang Jennifer A. Woyach CorrespondenceOpen Access20 Feb 2025 Blood Cancer Journal Volume: 15, P: 23 Treatment with obinutuzumab plus venetoclax reshapes ...
Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients Paul J. Hengeveld Joyce Schilperoord-Vermeulen Anton W. Langerak CorrespondenceOpen Access07 Jan 2025Blood Cancer Journal Volume: 15, P: 2 CANAIRI: the Collaboration for Translational Artificial Intelligence Trials...
Latest Conference Coverage Dr Coombs on the Challenges in Establishing a Treatment Consensus for Relapsed CLL Efficacy and Safety of Nadofaragene Firadenovec Hold Up in NMIBC Real-World Study Durvalumab Plus Chemo May be Promising Neoadjuvant Option in UTUC Dr Patel on the Potential for Adjuvant ...
Increase your personal adds of survival by empowering yourself with the latest news and research on Leukaemia, (leukemia), which you can incorporate today into personal integrative cancer treatment programme. "It's really great to have so many easy to read articles in one place. Thank you CANCER...
Here is a roundup of the latest news and updates for patients with Chronic Lymphocytic Leukemia from CURE. Known as the most common form of leukemia found in adults, chronic lymphocytic leukemia (CLL) has seen an influx of research in recent weeks. Here, CURE® takes a look back at some...